News
IVBIY
45.38
NaN%
--
Innovent Biologics reports FY results
Seeking Alpha · 03/26 11:39
Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies
Seeking Alpha · 03/06 11:05
China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition
Seeking Alpha · 03/06 07:27
Eli Lilly expands partnership with Innovent to develop oncology, immunology drugs
Seeking Alpha · 02/08 15:33
I Expect Novo Nordisk To Outperform Eli Lilly In 2026: Here's Why
Seeking Alpha · 01/05 14:53
Notable healthcare headlines for the week: UnitedHealth, Molina Healthcare, and Novo Nordisk in focus
Seeking Alpha · 01/04 14:05
Eli Lilly, Novo waging price wars as obesity drug market heats up in China
Seeking Alpha · 12/30/2025 12:43
Notable healthcare headlines for the week: UnitedHealth, Molina and Roche in focus
Seeking Alpha · 10/26/2025 13:05
Reported Earlier, Takeda And Innovent Biologics Collaborate To Develop, Manufacture And Commercialize IBI363 IBI343 Worldwide Outside Greater China With U.S. Co-Commercialization
Benzinga · 10/22/2025 07:41
Innovent inks $11.4 billion cancer drug partnership with Japan's Takeda
Seeking Alpha · 10/22/2025 05:55
Weekly Report: what happened at IVBIY last week (0908-0912)?
Weekly Report · 09/15/2025 11:22
Weekly Report: what happened at IVBIY last week (0901-0905)?
Weekly Report · 09/08/2025 11:25
Weekly Report: what happened at IVBIY last week (0825-0829)?
Weekly Report · 09/01/2025 11:19
Innovent Biologics reports interim results
Seeking Alpha · 08/27/2025 10:27
Weekly Report: what happened at IVBIY last week (0818-0822)?
Weekly Report · 08/25/2025 11:31
Weekly Report: what happened at IVBIY last week (0811-0815)?
Weekly Report · 08/18/2025 11:22
Weekly Report: what happened at IVBIY last week (0804-0808)?
Weekly Report · 08/11/2025 11:30
Weekly Report: what happened at IVBIY last week (0728-0801)?
Weekly Report · 08/04/2025 11:33
Novo Nordisk: Is This An Overreaction Or The End Of The GLP-1 Fairy Tale?
Seeking Alpha · 07/30/2025 13:00
Weekly Report: what happened at IVBIY last week (0721-0725)?
Weekly Report · 07/28/2025 11:33
More
Webull provides a variety of real-time IVBIY stock news. You can receive the latest news about Innovent Biologi through multiple platforms. This information may help you make smarter investment decisions.
About IVBIY
Innovent Biologics Inc is an investment holding company principally engaged in the research, development, production and sales of innovative medicines for the treatment of diseases such as cancer, cardiovascular and metabolic (CVM), autoimmune and eye diseases. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The Company mainly conducts its businesses within domestic and overseas markets.